Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets

Pharmazie

Volumn 62, Issue 4, 2007, Pages 278-283

  Dahiya, Sunita ^a   Pathak, K ^a  

^a NH 2   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACECLOFENAC;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; POWDER DIFFRACTION; SCANNING ELECTRON MICROSCOPY; TABLET; TABLET COMPRESSION;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CRYSTALLOGRAPHY, X-RAY; CYCLODEXTRINS; DICLOFENAC; EXCIPIENTS; HARDNESS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS;

EID: 34247149793     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.4.6129     Document Type: Article

References (25)

1. Aly AL, Qato MK, Ahmad MO (2003) Enhancement of the dissolution rate and bioavailability of glipizide through cyclodextrin inclusion complex. Pharm Technol 6: 54-62.
2. Bekers O, Uijtendal EV, Beijnen JH, Bult A, Underberg WJ (1991) Cyclodextrins in pharmaceutical field. Drug Dev Ind Pharm 17: 1503-1549.
3. Costa P, Lobo JMS (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13: 123-133.
4. Donbrow M, Tomitou E (1978) Estimation of dissolution rate of salicylamide in complexing media using a theoretical diffusion model. J Pharm Sci 67: 95-98.
5. Duchene D, Wouessidjewe D (1990) Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev Ind Pharm 16: 2487-2499.
6. Gandhi RB, Karara AH (1988) Characterization, dissolution and diffusion properties of tolbutamide-β-cyclodextrin complex systems. Drug Dev Ind Pharm 14: 657-682.
7. Gibaud S, Zirar SB, Mutzenhardt P, Fries I, Astier A (2005) Melarsoprolcyclodextrins inclusion complexes. Int J Pharm 306: 107-121.
8. Gladys G, Claudia G, Marcela L (2003) The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β- cyclodextrin. Eur J Pharm Sci 20: 285-293.
9. Higuchi T, Connors KA (1965) Phase solubility techniques. In: Reilly CN (ed.) Advances in analytical chemistry instrumentation, Interscience, New York, p. 117-212.
10. Jug M, Becirevik-Lacan M (2004) Influence of hydroxypropyl-β- cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 21: 251-260.
11. Khan KA (1975) The concept of dissolution efficiency. J Pharm Pharmacol 27: 48-49.
12. Kumar KR, Madhusudan S, Prahlad T (2005) Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat. Eur J Pharm Biopharm 60: 39-46.
13. Lopez ME, Torres-Labandeira JJ, Seijo LC, Penin LS, Vila-Jato JL (2000) Complexation of the interferon inducer bropirimine with HPβCD. Eur J Pharm Sci 9: 381-386.
14. Mishra PR, Mishra M, Namdeo A, Jain NK (1999) Pharmaceutical potential of cyclodextrins. Indian J Pharm Sci 61: 193-198.
15. Mura P, Zerrouk N, Faucci MT, Maestrelli F, Chemtob C (2002) Comparative study of ibuproxam complexation with amorphous β-cyclodextrin derivative in solution and in solid state. Eur J Pharm Biopharm 54: 181-191.
16. Nagarsenkar MS, Shenai H (1996) Influence of hydroxypropyl-β- cyclodextrin on solubility and dissolution profile of ketoprofen in its solid dispersions. Drug Dev Ind Pharm 22: 987-992.
17. Naidu NB, Chowdary KPR, Murthy KVR, Satyanarayana V, Hayman AR, Becket G (2004) Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J Pharm Biomed Anal 35: 75-86.
18. Nalluri BN, Chowdary KPR, Murthy KVR, Hayman AR, Becket G (2003) Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech 4: 1-12.
19. Prahlad T, Kumar KR (2004) Study of freeze dried quercetin-cyclodextrin binary systems by DSC, FTIR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 34: 333-339.
20. Sweetman SC (2002) Martindale: The complete drug reference. The Pharmaceutical Press, Great Britain, p. 11.
21. Uekama K, Narisawa S, Hirayama F, Otagiri M (1983) Improvement of dissolution and absorption characteristics of benzodiazepine-cyclodextrin complexation. Int J Pharm 6: 327-338.
22. Ugwu SO, Alcala MT, Bhardwaj R, Blanchard J (1999) Characterization of the complexation of diflunisal with hydroxypropyl-β-cyclodextrin. J Pharm Biomed Anal 19: 391-397.
23. United States Pharmacopoeia 23 - NF 18 (1995) Asian ed., Rockville, MD, p. 2053.
24. Ventura CA, Tommasini S, Falcone A, Giannone I, Paolino D, Sdrafkakis V, Mondello MR, Puglisi G (2006) Influence of modified cyclodextrin on solubility and percutaneous absorption of celecoxib through human skin. Int J Pharm 314: 37-45.
25. Yuksel N, Kanik AE, Baykara T (2000) Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and model-independent methods. Int J Pharm 209: 57-67.